Insilico Medicine announced Longevity Grok on November 6, 2026, an open-source system that uses up to 30 AI agents on Grok Bot to organize fragmented health records, propose interventions and score later biomarker results. The clinical-stage generative AI drug discovery company developed the project with Harvard Medical School researcher David Sinclair and paired the personal assistant with an opt-in aging-research network. The Longevity Grok product site dates the client and Mothership…